Clinical trialNCT02783950CompletedInterventional

Genomics in Michigan Impacting Observation or Radiation

SponsorUniversity of Michigan Rogel Cancer CenterEnrollment356Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine the impact of Decipher test results on adjuvant treatment decisions of high-risk post-RP patients with undetectable post-op prostate specific antigen (PSA) compared to clinical factors alone.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Cher, MD
Wayne State University
Principal Investigator
clinicaltrials.gov ↗
Todd Morgan, MD
University of Michigan
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Michigan Hospital and Health Systems
Ann Arbor, Michigan, United States
Henry Ford Hospital
Detroit, Michigan, United States
Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
Michigan Urological Clinic
Grand Rapids, Michigan, United States
Spectrum Health Medical Group- Urology
Grand Rapids, Michigan, United States
Urologic Consultants
Grand Rapids, Michigan, United States
Urology Associates of Grand Rapids
Grand Rapids, Michigan, United States
Urology Surgeons, Pc
Grand Rapids, Michigan, United States
Comprehensive Medical Center, Pllc
Royal Oak, Michigan, United States
Tri-City Urology
Saginaw, Michigan, United States
Bay Area Urology Associates, Pc
Traverse City, Michigan, United States
Michigan Institute of Urology-Town Center
Troy, Michigan, United States
Iha Urology at St. Joe'S Ann Arbor
Ypsilanti, Michigan, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jan 2017
Primary completion: 1 Feb 2020
Completion: 2 Apr 2024
Last update posted: 26 Sept 2024
Registered enrollment: 356
Registry id: NCT02783950

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.